EarLy Surveillance for Autoimmune diabetes: protocol for a qualitative study of general population and stakeholder perspectives on screening for type 1 diabetes in the UK (ELSA 1). Issue 2 (21st April 2022)

• Record Type: Journal Article
• Authors: Quinn, Lauren Marie; Shukla, David; Greenfield, Sheila Margaret; Barrett, Tim; Garstang, Joanna; Boardman, Felicity; Litchfield, Ian; Dayan, Colin; Gardner, Christine; Connop, Clair; Lepley, Amanda; Narendran, Parth
• Is Part Of: BMJ open diabetes research and care. Volume 10:Issue 2(2022)
• Publication Date: 2022-04-21
• Subjects: diabetes mellitus, type 1 -- qualitative research -- antibodies -- prediabetic state; Diabetes -- Periodicals; 616.462005
• DOI: 10.1136/bmjdrc-2021-002750
• Languages: English
• ISSNs: 2052-4897

Abstract

Abstract : Objective: Type 1 diabetes (T1D) is the most common form of diabetes in children, accounting for 96% of cases, with 29 000 children affected in the UK. Studies have recently identified immunotherapies that safely delay the development of T1D for at least 3 years, and further therapies are in development. General population screening programs in other countries can now accurately identify children with presymptomatic T1D who can be entered into prevention studies. The UK does not have such a system in place. We aim to explore whether parents and children in the UK would want to be part of such a program of testing for T1D in the general population, how they would want to be informed and participate in such a program, and how any barriers to recruitment and participation can be addressed. Additionally, the views of stakeholders who would be involved in the testing program will be collected and analyzed. Research design and methods: We will interview parents/guardians and children aged 3–13 years about their views on screening for T1D. We will recruit purposefully to ensure representation across ethnicities and socioeconomic groups. Interviews will be transcribed, analyzed and used to inform iterative co-design work with additional families to address any issues raised. Similar qualitative work will be undertaken with professional stakeholders who would be involved in implementing any future screening program. Where possible, all aspects of this study will be performed remotely by phone or online to minimize infection risk. Conclusions: This qualitative study will provide the first insights into acceptability of testing and monitoring for T1D in the general population from the perspective of families and stakeholders in the UK. Co-design work will help establish the barriers and identify strategies to mitigate and overcome these issues, as an important step towards consideration of national testing for T1D.